Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    2-amino-2-methyl-N-[(2R)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Purchase MK-677 Ibutamoren Capsules to Boost GH Levels
    Purchase MK-677 Ibutamoren Capsules to Boost GH Levels

    09 Aug 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-08-09/buy-mk-677-ibutamoren-capsules-increase-gh-levels-with-capsules

    PHARMIWEB
    09 Aug 2025
    Share Share
    NewLink Genetics Stockholders Approve Merger with Lumos Pharma
    NewLink Genetics Stockholders Approve Merger with Lumos Pharma

    18 Mar 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/newlink-genetics-stockholders-approve-merger-with-lumos-pharma/?s=79

    BIOSPACE
    18 Mar 2020
    Share Share